(Q22241697)

30 November 2017

0 references

1 reference

title

Dopamine and antipsychotic drug action revisited (English)

1 reference

30 November 2017

0 references

Jones HM

1

H M

Jones

1 reference

30 November 2017

Pilowsky LS

series ordinal

2

author given names

L S

author last names

Pilowsky

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

British Journal of Psychiatry

30 November 2017

published in

2 references

30 November 2017

volume

181

1 reference

30 November 2017

issue

4

0 references

page(s)

271-275

1 reference

Increased brain dopamine and dopamine receptors in schizophrenia.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Limbic selectivity of clozapine

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

The cerebral cortex: a case for a common site of action of antipsychotics

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Cognition, schizophrenia, and the atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

The use of high-dose antipsychotic medication

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.181.4.271

7 January 2021

Identifiers

DOI

10.1192/BJP.181.4.271

1 reference

30 November 2017

1 reference